Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

By Diego J. Covarrubias, P. Luetmer, Norbert G. Campeau. AJNR. American journal of neuroradiology, 2002

652 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Reversible posterior leukoencephalopathy syndrome (2010, background): “Presence of ischaemia, haemorrhage, gadolinium enhancement, and extensive oedema are associated with poorer outcome [40].”
Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome (2007, background): “neurotoxic syndrome, eclampsia, and the PRES imaging appearance has been described previously.(1-17) Two experienced neuroradiolo-”
Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. (2007, background): “7%) than expected from the literature [4, 20, 39]; the exception is a study noting enhancement in 33% of patients [6].”
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features (2008, background): “With similar clinical/imaging presentation recognized the mid 1990s, additional associations were noted (autoimmune conditions, thrombotic thrombocytopenic purpura, and medical renal disease), and the term “PRES” was introduced.(15,20,22) PRES is seen with unique or high-dose cancer chemotherapy (Ta”